Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 17 | 2023 | 97 | 5.610 |
Why?
|
| Bariatric Surgery | 12 | 2023 | 51 | 3.380 |
Why?
|
| Gastric Bypass | 12 | 2023 | 68 | 3.190 |
Why?
|
| Weight Loss | 9 | 2022 | 121 | 1.820 |
Why?
|
| Gastrectomy | 6 | 2023 | 28 | 1.680 |
Why?
|
| Laparoscopy | 11 | 2022 | 184 | 1.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2022 | 148 | 1.190 |
Why?
|
| Postoperative Complications | 6 | 2023 | 810 | 1.120 |
Why?
|
| Cholecystitis | 1 | 2023 | 8 | 0.800 |
Why?
|
| Gallstones | 1 | 2023 | 6 | 0.800 |
Why?
|
| Cefoxitin | 1 | 2020 | 3 | 0.650 |
Why?
|
| Metronidazole | 1 | 2020 | 5 | 0.650 |
Why?
|
| Levofloxacin | 1 | 2020 | 3 | 0.650 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 25 | 0.640 |
Why?
|
| Reoperation | 3 | 2021 | 743 | 0.610 |
Why?
|
| Health Status Disparities | 1 | 2020 | 63 | 0.600 |
Why?
|
| Gastroplasty | 1 | 2019 | 27 | 0.580 |
Why?
|
| Middle Aged | 18 | 2022 | 7911 | 0.560 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 2 | 0.540 |
Why?
|
| Ideal Body Weight | 1 | 2017 | 3 | 0.540 |
Why?
|
| Adult | 15 | 2022 | 6921 | 0.530 |
Why?
|
| Gene Expression | 1 | 2017 | 178 | 0.510 |
Why?
|
| Length of Stay | 2 | 2020 | 297 | 0.510 |
Why?
|
| Humans | 23 | 2023 | 22903 | 0.480 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 35 | 0.470 |
Why?
|
| Female | 17 | 2022 | 12934 | 0.460 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2985 | 0.420 |
Why?
|
| Obesity | 4 | 2022 | 288 | 0.420 |
Why?
|
| Male | 15 | 2022 | 12453 | 0.420 |
Why?
|
| Body Mass Index | 6 | 2020 | 377 | 0.360 |
Why?
|
| Quality of Life | 1 | 2016 | 557 | 0.350 |
Why?
|
| Treatment Outcome | 6 | 2022 | 2939 | 0.350 |
Why?
|
| Postoperative Period | 4 | 2020 | 237 | 0.350 |
Why?
|
| Case-Control Studies | 4 | 2019 | 479 | 0.290 |
Why?
|
| Bone Density | 2 | 2020 | 146 | 0.280 |
Why?
|
| Prospective Studies | 8 | 2022 | 1493 | 0.270 |
Why?
|
| Prognosis | 2 | 2020 | 728 | 0.230 |
Why?
|
| United States | 3 | 2022 | 1765 | 0.220 |
Why?
|
| Insulin | 2 | 2016 | 77 | 0.210 |
Why?
|
| Aged | 7 | 2022 | 7435 | 0.210 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2023 | 3 | 0.200 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 1409 | 0.190 |
Why?
|
| Patient Readmission | 2 | 2021 | 117 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 25 | 0.170 |
Why?
|
| Biomarkers | 2 | 2020 | 473 | 0.170 |
Why?
|
| Preoperative Period | 2 | 2019 | 65 | 0.170 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 57 | 0.160 |
Why?
|
| Mental Disorders | 1 | 2022 | 134 | 0.160 |
Why?
|
| Abdominal Muscles | 1 | 2020 | 6 | 0.160 |
Why?
|
| Osteoclasts | 1 | 2020 | 20 | 0.160 |
Why?
|
| Antiemetics | 1 | 2020 | 10 | 0.160 |
Why?
|
| Protein Precursors | 1 | 2019 | 17 | 0.150 |
Why?
|
| Morphine | 1 | 2020 | 70 | 0.150 |
Why?
|
| Fractures, Bone | 1 | 2020 | 70 | 0.150 |
Why?
|
| Neoplasms | 1 | 2022 | 218 | 0.150 |
Why?
|
| Nerve Block | 1 | 2020 | 61 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2020 | 308 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 107 | 0.140 |
Why?
|
| Risk Factors | 3 | 2021 | 1971 | 0.140 |
Why?
|
| Incidence | 2 | 2022 | 624 | 0.140 |
Why?
|
| Time Factors | 3 | 2016 | 1257 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2017 | 13 | 0.140 |
Why?
|
| Anemia | 1 | 2017 | 30 | 0.130 |
Why?
|
| Young Adult | 2 | 2020 | 1651 | 0.130 |
Why?
|
| Adolescent | 2 | 2020 | 1880 | 0.130 |
Why?
|
| Operative Time | 1 | 2017 | 81 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 361 | 0.130 |
Why?
|
| Blotting, Western | 1 | 2017 | 132 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 210 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 42 | 0.130 |
Why?
|
| Cystectomy | 1 | 2017 | 8 | 0.130 |
Why?
|
| Urinary Bladder | 1 | 2017 | 18 | 0.130 |
Why?
|
| Patient Discharge | 1 | 2017 | 147 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 387 | 0.120 |
Why?
|
| Hypertension | 1 | 2017 | 163 | 0.120 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 26 | 0.120 |
Why?
|
| Weight Gain | 1 | 2016 | 61 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 289 | 0.120 |
Why?
|
| Age Factors | 1 | 2017 | 636 | 0.120 |
Why?
|
| Mental Health | 1 | 2016 | 94 | 0.110 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2013 | 5 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 356 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2013 | 48 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 121 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2013 | 73 | 0.100 |
Why?
|
| Exercise | 1 | 2016 | 392 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2022 | 1414 | 0.060 |
Why?
|
| Fibronectins | 1 | 2022 | 17 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 92 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2021 | 129 | 0.040 |
Why?
|
| Morbidity | 1 | 2020 | 50 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 190 | 0.040 |
Why?
|
| Postmenopause | 1 | 2019 | 57 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2019 | 227 | 0.040 |
Why?
|
| Comorbidity | 1 | 2019 | 426 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2017 | 26 | 0.030 |
Why?
|
| Ureter | 1 | 2017 | 27 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 272 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 33 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2017 | 106 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 107 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 268 | 0.030 |
Why?
|
| Lipids | 1 | 2014 | 45 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 13 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2014 | 103 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 86 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 166 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 3720 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2014 | 547 | 0.020 |
Why?
|